CL
MIST icon

CSS LLC’s Milestone Pharmaceuticals MIST Stock Holding History

CSS LLC’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,008
Closed -$5.31K – 1044
2022
Q3 		$9K Buy
+1,008
New +$7.64K ﹤0.01% 971

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CSS LLC's MIST Position: Q4 2022 in Review

CSS LLC sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 1,008 shares — an estimated $5.31K sold.

CSS LLC first reported a position in MIST in Q3 2022 and held it in 1 quarter. The position peaked at $9K in Q3 2022. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

  • CSS LLC reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 1,008 Milestone Pharmaceuticals shares in Q4 2022, an estimated $5.31K.
  • CSS LLC first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • CSS LLC's Milestone Pharmaceuticals position peaked at $9K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.